The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Biological versus chronological ovarian age: implications for assisted reproductive technology
Open accessAbstract
BACKGROUND: Women have been able to delay childbearing since effective contraception became available in the 1960s. However, fertility decreases with increasing maternal age. A slow but steady decrease in fertility is observed in women aged between 30 and 35 years, which is followed by an accelerated decline among women aged over 35 years. A combination of delayed childbearing and reduced fecundity with increasing age has resulted in an increased number and proportion of women of greater than or equal to 35 years of age seeking assisted reproductive technology (ART) treatment. METHODS: Literature searches supplemented with the authors' knowledge. RESULTS: Despite major advances in medical technology, there is currently no ART treatment strategy that can fully compensate for the natural decline in fertility with increasing female age. Although chronological age is the most important predictor of ovarian response to follicle-stimulating hormone, the rate of reproductive ageing and ovarian sensitivity to gonadotrophins varies considerably among individuals. Both environmental and genetic factors contribute to depletion of the ovarian oocyte pool and reduction in oocyte quality. Thus, biological and chronological ovarian age are not always equivalent. Furthermore, biological age is more important than chronological age in predicting the outcome of ART. As older patients present increasingly for ART treatment, it will become more important to critically assess prognosis, counsel appropriately and optimize treatment strategies. Several genetic markers and biomarkers (such as anti-Müllerian hormone and the antral follicle count) are emerging that can identify women with accelerated biological ovarian ageing. Potential strategies for improving ovarian response include the use of luteinizing hormone (LH) and growth hormone (GH). When endogenous LH levels are heavily suppressed by gonadotrophin-releasing hormone analogues, LH supplementation may help to optimize treatment outcomes for women with biologically older ovaries. Exogenous GH may improve oocyte development and counteract the age-related decline of oocyte quality. The effects of GH may be mediated by insulin-like growth factor-I, which works synergistically with follicle-stimulating hormone on granulosa and theca cells. CONCLUSION: Patients with biologically older ovaries may benefit from a tailored approach based on individual patient characteristics. Among the most promising adjuvant therapies for improving ART outcomes in women of advanced reproductive age are the administration of exogenous LH or GH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial and cyclic recruitment of ovarian follicles
McGee, E. A., & Hsueh, A. J. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0394 · Cited by 1,771
The variability of female reproductive ageing
te Velde, E. R. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.2.141 · Cited by 1,214
Leridon, H. (2004) · Human Reproduction · doi:10.1093/humrep/deh304 · Cited by 507
Menstrual cyclicity and the pre-menopause
Treloar, A. E. (1981) · Maturitas · doi:10.1016/0378-5122(81)90032-3 · Cited by 365
Cited by
Ovarian ageing: the role of mitochondria in oocytes and follicles
May-Panloup, P., Boucret, L., Chao de la Barca, J.-M., Desquiret-Dumas, V., Ferré-L'Hotellier, V., Morinière, C., Descamps, P., Procaccio, V., & Reynier, P. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw028 · Cited by 577
Gerber, B., von Minckwitz, G., Stehle, H., Reimer, T., Felberbaum, R., Maass, N., Fischer, D., Sommer, H. L., Conrad, B., Ortmann, O., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5704 · Cited by 297
Absolute Risks of Obstetric Outcomes Risks by Maternal Age at First Birth: A Population-based Cohort
Schummers, L., Hutcheon, J. A., Hacker, M. R., VanderWeele, T. J., Williams, P. L., McElrath, T. F., & Hernandez-Diaz, S. (2018) · Epidemiology · doi:10.1097/ede.0000000000000818 · Cited by 96
Factors influencing natural fecundity in fertile couples: a survey of puerperae and their partners
Matorras, R., Malaina, I., Anibal, N., Limia, I., & Rodríguez-Gómez, L. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.103751 · Cited by 4
Metadata
- Authors
- Alviggi, C., Humaidan, P., Howles, C. M., Tredway, D., & Hillier, S. G.
- Venue
- Reproductive Biology and Endocrinology
- Published
- 2009-09-22
- Volume
- 7
- Issue
- 1
- Pages
- 101-101
- ISSN
- 1477-7827 (ISSN-L)
- OpenAlex
- W2125639197
- Cited by
- 160
- References
- 4
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biological versus chronological ovarian age: implications for assisted reproductive technology. https://app.cochat.ai/papers/10.1186/1477-7827-7-101
- The paper
- Alviggi, C., Humaidan, P., Howles, C. M., Tredway, D., & Hillier, S. G. (2009). Biological versus chronological ovarian age: implications for assisted reproductive technology. Reproductive Biology and Endocrinology. https://doi.org/10.1186/1477-7827-7-101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.